Navigation Links
Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
Date:10/27/2011

ntsAs AdjustedGAAPAs AdjustedNet sales

$   725,295$
-$   725,295$   641,322$
-$   641,32213%13%Cost of sales

497,71642,362

(a,b)

455,354427,3687,174

(a)

420,19416%8%Gross profit

227,57942,362269,941213,9547,174221,1286%22%Operating expensesDistribution

10,264-10,2648,333-8,33323%23%Research and development

19,638(3,500)

(c)

23,13817,727-17,72711%31%Selling and administration

96,12513,620

(a,d)

82,50576,1274,113

(a)

72,01426%15%Total

126,02710,120115,907102,1874,11398,074Operating income

101,55252,482154,034111,76711,287123,054-9%25%Interest, net

12,570-12,57010,087-10,08725%25%Other expense (income), net

229-229(559)-(559)--Income from continuing operations before income taxes

88,75352,482141,235102,23911,287113,526-13%24%Income tax expense

18,29519,620

(e)

37,91528,5613,615

(e)

32,176-36%18%Income from continuing operations

$
70,458$
32,862$   103,320$
73,678$
7,672$
81,350-4%27%Diluted earnings per share from continuing operations

$
.75$
.10$
.79$
.87-5%26%Diluted weighted average shares outstanding

93,95393,95393,26993,269Selected ratios as a percentage of net sales   Gross profit

31.4%37.2%33.4%34.5%   Operating expenses

17.4%16.0%15.9%15.3%   Operating income

14.0%21.2%17.4%19.2%(a) Deal-related amortization(b) Inventory step-up of $27,179(c) Proceeds from sale of pipeline research and development projects(d) Acquisition-related costs of $8,782(e) Total tax effect for non-GAAP pre-tax adjustmentsTable IIPERRIGO COMPANYREPORTABLE SEGMENTSRECONCILIATION OF NON-GAAP MEASURES(in thousands)(unaudited)Three Months EndedConsumer HealthcareSeptember 24, 2011September 25, 2010% ChangeGAAPNon-GAAP AdjustmentsAs AdjustedGAAPNon-GAAP AdjustmentsAs AdjustedGAAPAs AdjustedNet sales'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... DIEGO y PARÍS, 24 de mayo ... VOLC ), un destacado desarrollador y fabricante de ... mejorar la diagnosis y tratamiento de la enfermedad ... preliminares del ensayo ADVISE ( Ad enosine ... E valuation) II durante la sesión de ...
(Date:5/23/2013)... May 23, 2013 Amgen (NASDAQ: AMGN ... Annual  Healthcare Conference on Thursday, May 30, 2013, at the ... at 9:20 a.m. Eastern Daylight Time. Arvind Sood ... present at the conference. Live audio of the presentation can ... www.amgen.com , under Investors. A replay of the webcast will ...
(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated pharmaceutical company ... ("PRC"), today announced that it held its 2011 Annual ... 2011, in Harbin, PRC. At the Annual ...
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that China,s State ... Company,s real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene ... companion diagnostic test for the use of a targeted ...
Cached Medicine Technology:China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting 2China Medical Technologies Receives SFDA Approval for its PCR-based KRAS Assay for Colorectal Cancer Targeted Drug 2
(Date:5/23/2013)... May 23, 2013 Susquehanna Health ... offering a comprehensive babysitting training course for adolescents age ... developed by Indianapolis pediatrician Dr. Patricia Keener after a ... of an adult sitter who didn’t know how to ... development program with a medical basis that aims to ...
(Date:5/23/2013)... - Even while being dragged to its destruction ... fires away, sending signals that thwart the development ... reported in an early online publication at ... often encountered by tumors, the epidermal growth factor ... an international team led by scientists at The ...
(Date:5/23/2013)... Clinic researchers have used next generation genomic analysis to ... tumors have similar genetic origins, which may help in ... the journal Cancer Research . , "This is ... generation sequencing in adjacent Gleason patterns in the same ... pathology," says ,John Cheville, M.D., Mayo Clinic pathologist and ...
(Date:5/23/2013)... Rottenstein Law Group LLP, a New York-based nationwide mass ... Center at http://www.rotlaw.com/tylenol , dedicated to issues that ... filing lawsuits. , The painkiller Tylenol (acetaminophen) has ... to a 2009 report from the U.S. Food and ... warned consumers against using more than the recommended dose ...
(Date:5/23/2013)... Dr. Katherine Ahn is proud to ... County, OCCares , will hold its first community event ... details are as follows: , Sunday May 26th, 2013 from ... Garden Grove, CA 92843 , The benefit celebration will feature ... Charmaine & Jonathan Thulin. There will also be piano, ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 3
... failure by official bodies to halt the distribution of ... been incidents caused by E. coli contamination in ... food. , Around 200 persons were affected ... was the collapse of both kidneys of a three-year-old ...
... huge doping scam burst into the open in Paris, ... suspended for three months by the// Californian state authorities. ... the Bay Area Laboratory Co-Operative that allegedly provided steroids ... placed on five years' probation and ordered to undergo ...
... increased rates of serious infections caused by strains ... the current childhood pneumococcal vaccine,// according to a ... conjugate vaccine (PCV7), Alaska Native children and adults ... compared with non–Native Alaskans. Introduction of PCV7 into ...
... Stroke patients in rural hospitals can get safe, effective ... a doctor from a larger hospital is on the ... implications for overcoming barriers to optimal stroke care in ... of this treatment over the telephone appears to be ...
... experience hot flashes: unpredictable, sometimes disruptive, periods of intense ... generations of physicians have prescribed hormones to reduce these ... causes of hot flashes. ,Three new studies explore ... contributing to – or lessening – the intensity and ...
... medical representatives needs no introduction. The motivation for such ... and boardrooms, where jet-setting corporate executives are given their ... sheer bottom-line figures, the dynamic medical rep gets to ... medical representatives first create a ready reckoner of the ...
Cached Medicine News:Health News:U.S Officials Worried Over Failure In Preventing Food Contamination 2Health News:US Psychiatrist Suspended from Practicing Medicine for Involvement in Doping Scam 2Health News:US Psychiatrist Suspended from Practicing Medicine for Involvement in Doping Scam 3Health News:Increase in Pneumococcal Infections That are Not Covered by Vaccine 2Health News:Hot Flashes: Studies Explore the Various Possibilities Involved 2Health News:Hot Flashes: Studies Explore the Various Possibilities Involved 3Health News:Art of Establishing a Bond to Sell a Brand – Medical Reps Show the Wa 2
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... Sugar-Chex Linearity is a whole blood ... reportable range of the most popular ... recommendations of using a control matrix ... Linearity is packaged in ready-to-use dropper ...
Medicine Products: